Health Condition 1: K746- Other and unspecified cirrhosis ofliver
Conditions
Interventions
Intervention1: Omega 3 fatty acid: 10% Omega-3 fatty acid oil will be supplemented in intravenous form from preoperative day1, intraoperatively (anytime during surgery before reperfusion of graft) an
Sponsors
Institute of liver and biliary sciences
Eligibility
Inclusion criteria
Inclusion criteria: All elective liver transplant recipients Adult patients Those who consent
Exclusion criteria
Exclusion criteria: Liver transplantation for fulminant hepatic failure Re-transplantation Known allergy to the study emulsion
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To study the effect of omega-3 fatty acids supplementation on recipients in LDLT and correlation with early allograft dysfunctionTimepoint: Post operative day 7 | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of hospital stayTimepoint: Till discharge;Duration of ICU stayTimepoint: Till discharge;Post-operative complicationsTimepoint: Till discharge;To study the correlation between supplementation of omega-3 fatty acids and trend in post-operative LFTsTimepoint: Till discharge;To study the effect of Omega-3 fatty acids supplementation on liver regeneration by CT volumetryTimepoint: Post operative day 7 | — |
Countries
India
Contacts
Public ContactDr Viniyendra Pamecha
ILBS, New Delhi
Outcome results
None listed